Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway
Acta Pharmacologica Sinica2012Vol. 33(4), pp. 479–489
Citations Over TimeTop 18% of 2012 papers
Bo Ma, Qi Zhang, Di Wu, Yonglu Wang, Yingying Hu, Yanping Cheng, Zhen‐Dong Yang, Ya-ya Zheng, Hanjie Ying
Related Papers
- → Aging effect of osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in human periodontal ligament cells under continuous static pressure.(2022)3 cited
- [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention].(2012)
- [Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages].(2011)
- Different expressing levels of osteoprotegerin and receptor activator of nuclear factor-κB ligand from osteoblasts of young, adult and aged mice(2005)
- EFFECTS OF 1α,25(OH)_2D_3 ON THE EXPRESSION OF RECEPTOR ACTIVATOR OF NF-КB LIGAND AND OSTEOPROTEGERIN IN RAT OSTEOBLASTS IN VITRO(2010)